An Open-label, Multicentre, Parallel Group Trial to Investigate the Return of Ovarian Function Following the Administration of Two ZOLADEX 10.8 mg Depots or Six ZOLADEX 3.6 mg Depots in Women With Endometriosis - Follow on Study from Trial 9393IL/0026
Study identifier:9393IL/0027
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An Open-label, Multicentre, Parallel Group Trial to Investigate the Return of Ovarian Function Following the Administration of Two ZOLADEX 10.8 mg Depots or Six ZOLADEX 3.6 mg Depots in Women With Endometriosis - Follow on Study from Trial 9393IL/0026
Medical condition
endometriosis
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
